文献速递焦虑、强迫与应激相关障碍

聚焦超声新型双侧内囊前肢毁损术治疗难治性强迫症的长期临床结局

Long-term clinical outcome of a novel bilateral capsulotomy with focused ultrasound in refractory obsessive-compulsive disorder treatment.
PubMed 文献 · Mol Psychiatry · 2024-10-28

该研究纳入2013至2014年间接受MRgFUS内囊前肢毁损术的11例难治性强迫症患者中的10例,随访10年后Y-BOCS评分平均改善52.3%,7例完全应答、2例缓解,强迫症状与整体功能均显著改善,未报告不良事件。

要点

  • 随访10年后Y-BOCS评分平均改善52.3%,7/10完全应答,2例达缓解。
  • Y-BOCS由2年时20.7降至10年时16.4(p=0.012),整体功能由57.4升至69.0(p=0.011)。
  • 额叶相关功能FrSBe总分由91.0±17.6降至78.6±17.7(p<0.05),未报告自杀或神经功能缺损等不良事件。

核心结论

  • MRgFUS内囊前肢毁损术对严重难治性强迫症有效且安全,疗效可持续至10年。

研究设计与样本

  • 纳入2013至2014年间接受MRgFUS内囊前肢毁损术治疗难治性强迫症的11例患者中的10例,随访10年,采用神经心理测验、额叶系统行为量表(FrSBe)和本地开发的MRgFUS患者中心结局问卷评估临床结局。

主要发现

  • 随访10年后Y-BOCS评分平均改善52.3%。
  • 10例中7例完全应答(Y-BOCS减分≥35%且CGI-I为1或2),其中2例达缓解(Y-BOCS≤12且CGI-S为1或2)。
  • 强迫症状显著减轻:Y-BOCS 2年时20.7 vs 10年时16.4(p=0.012)。
  • 整体功能显著改善:整体功能评估2年时57.4 vs 10年时69.0(p=0.011)。
  • 额叶相关功能显著改善:FrSBe总分术前91.0±17.6 vs 术后78.6±17.7(p<0.05);未报告包括自杀和神经功能缺损在内的不良事件;多数应答者对MRgFUS内囊前肢毁损术总体满意。

关键数值与推荐

  • 完全应答定义为Y-BOCS减分≥35%且CGI-I为1或2;缓解定义为Y-BOCS≤12且CGI-S为1或2。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Magnetic resonance-guided focused ultrasound (MRgFUS) capsulotomy is a promising treatment for refractory obsessive-compulsive disorder (OCD); however, long-term clinical outcome studies are lacking. We aimed to investigate the long-term efficacy and safety of MRgFUS capsulotomy in patients with refractory OCD. Ten of the eleven patients who underwent MRgFUS capsulotomy for treatment-resistant OCD between 2013 and 2014 were included in this study. Clinical outcomes were assessed after 10 years of follow-up post-MRgFUS capsulotomy using tools such as neuropsychological test, the Frontal Systems Behavior Scale (FrSBe), and a locally developed MRgFUS-patient-centered outcomes questionnaire. After 10 years of follow-up, there was a mean improvement of 52.3% in the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) score. Seven out of the ten participants responded fully (Y-BOCS reduction ≥35% + CGI-I 1 or 2) to the procedure, two of whom achieved remission (Y-BOCS score ≤12 and CGI-S 1 or 2). Obsessive-compulsive symptoms and overall functioning significantly reduced and improved, respectively (Y-BOCS = 20.7 after 2 years vs. 16.4 after 10 years, p = 0.012; Global Assessment of Functioning = 57.4 after 2 years vs. 69.0 after 10 years, p = 0.011). The patients experienced significantly improved frontal lobe-related functions (FrSBe Sum before 91.0 ± 17.6 vs. after 78.6 ± 17.7, p < 0.05). No adverse effects, including cases of suicide and neurological deficits, were reported. The majority of the respondents were generally satisfied with MRgFUS capsulotomy. MRgFUS capsulotomy is an effective and safe treatment option for the treatment of severe refractory OCD with sustained efficacy even after 10 years.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Chang KW, Chang JG, Jung HH, et al. Long-term clinical outcome of a novel bilateral capsulotomy with focused ultrasound in refractory obsessive-compulsive disorder treatment. Mol Psychiatry. 2024. PMID: 39468190. doi:10.1038/s41380-024-02799-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。